The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Reading Skin Cancer’s Molecular Fingerprint
Oncology Technology and innovation Molecular Pathology

Reading Skin Cancer’s Molecular Fingerprint

Machine-learning models analyzed Raman spectra to distinguish cancerous tissue from normal skin

10/13/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Reading Skin Cancer’s Molecular Fingerprint

At a Glance

CategoryDetail
ConditionNormal skin, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC)
Key MechanismsRaman spectroscopy uses laser light to generate tissue molecular fingerprints; machine-learning models classify patterns in the resulting spectra.
Target PopulationRemoved tissue samples of normal skin, BCC, and SCC; the study did not test patients directly.
Care SettingPreliminary analytical study of a handheld Raman spectroscopy system; biopsy with microscopic examination remains the standard diagnostic method.

Key Highlights

  • The study analyzed more than 50 removed tissue samples and almost 1,000 Raman spectra.
  • K-nearest neighbors and support vector machine models achieved approximately 84% overall accuracy.
  • The support vector machine had 78.7% sensitivity and 88.6% specificity.
  • A shallow neural network achieved 80.8% accuracy and an area under the receiver operating characteristic curve of 0.910.
  • Models distinguished normal skin from cancer more successfully than they distinguished BCC from SCC.

Guideline-Based Recommendations

Diagnosis

  • Biopsy followed by microscopic examination remains the standard method for diagnosing BCC and SCC.
  • The study evaluated analytical classification of removed tissue, not clinical diagnostic accuracy in patients.

Management

  • The article describes Raman spectroscopy as an investigational noninvasive tool that researchers are studying to help determine which lesions require further assessment.

Monitoring & Follow-up

    Risks

    • BCC and SCC can resemble benign or precancerous lesions.
    • The models had difficulty distinguishing BCC from SCC because their molecular patterns overlapped.
    • Reported performance was below the greater-than-90% sensitivity, specificity, and accuracy the researchers considered desirable for clinical use.

    Patient & Prescribing Data

    No patients were directly tested; the sample set comprised just over 50 removed tissue specimens of normal skin, BCC, and SCC.

    No treatment or prescribing data were reported. Biopsy with microscopic examination remains the standard diagnostic method.

    Clinical Best Practices

    • Use biopsy followed by microscopic examination as the standard diagnostic method, as stated in the article.
    • Interpret the reported Raman spectroscopy results as preliminary analytical performance, not established clinical diagnostic accuracy.
    • Account for the study’s small specimen set and the models’ difficulty separating BCC from SCC.

    Related Resources & Content

    • Proceedings of SPIE study described in the article

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

    Newsletters

    Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

    Newsletter Signup Image

    Explore More in Pathology

    Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

    False

    Advertisement

    Recommended

    False

    Affiliations:

    Specialties:

    Areas of Expertise:

    Contributions:

    False

    The Pathologist
    Subscribe

    About

    • About Us
    • Work at Conexiant Europe
    • Terms and Conditions
    • Privacy Policy
    • Your Privacy Choices
    • Advertise With Us
    • Contact Us

    Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.